1001 - 1010 of 6255 Results
Title
Year
-
OPENTitle: Exploring the reproducibility of functional connectivity alterations in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 11Start Page: e0188196End Page: e0188196Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0188196Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0188196&type=printableCitation Count: 80
-
OPENTitle: Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of OutcomeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 8Start Page: 983End Page: 991Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14089Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14089Citation Count: 3
- Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease2024OPENTitle: Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 9Start Page: 1103End Page: 1112Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14145Best OA location URL: https://doi.org/10.1002/mdc3.14145Citation Count: 6
- Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials2024OPENTitle: Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification TrialsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 11Start Page: 1345End Page: 1354Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14191Best OA location URL: https://doi.org/10.1002/mdc3.14191Citation Count: 0
-
OPENTitle: Disruption of Mitochondrial Complex I Induces Progressive ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 478End Page: 478Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28961Best OA location URL: https://doi.org/10.1002/mds.28961Citation Count: 11
- Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's disease2024OPENTitle: Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's diseaseJournal Name: Physiological ReportsPublisher: WileyVol: 12Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14814/phy2.16150Best OA location URL: https://doi.org/10.14814/phy2.16150Citation Count: 0
- Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial2024OPENTitle: Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trialJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 8Start Page: e0309217End Page: e0309217Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0309217Best OA location URL: https://doi.org/10.1371/journal.pone.0309217Citation Count: 0
- A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function2024OPENTitle: A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive functionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page: 5114End Page: 5131Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13858Best OA location URL: https://escholarship.org/content/qt6kd1j7bq/qt6kd1j7bq.pdfCitation Count: 35
- Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials2024OPENTitle: Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment TrialsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 6Start Page: 1225End Page: 1235Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230446Best OA location URL: https://doi.org/10.3233/jpd-230446Citation Count: 2
- Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD2024OPENTitle: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PDJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693Best OA location URL: https://doi.org/10.3389/fdgth.2024.1435693Citation Count: 2